Article
The Walgreens Flu Index is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country.
PRESS RELEASE
DEERFIELD, Ill., February 02, 2017 - The Walgreens Flu Index™ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170202005801/en/
The Flu Index shows which populations are experiencing the most incidences of influenza each week based on Index methodology. The data does not measure actual levels or severity of flu activity.
With the ability to generate hyper-local data across most U.S. markets, the Flu Index is an online, interactive resource allowing anyone to search and find information regarding the most current state of influenza in their community.
To view this week’s Walgreens Flu Index, maps and other online features, click here.
Top 10 DMAs for Flu Activity
Week of 01/29/2017
Top 10 States for Flu Activity
Week of 01/29/2017
Top 10 DMAs Flu Activity Gains
Week of 01/29/2017
Top 10 State Flu Activity Gains
Week of 01/29/2017
Methodology
The Walgreens Flu Index™ is compiled using weekly retail prescription data for antiviral medications used to treat influenza across Walgreens locations nationwide. The data is analyzed at state and geographic market levels to measure absolute impact and incremental change of antiviral medications on a per store average basis, and does not include markets in which Walgreens has fewer than 10 retail locations.
FDA Approves Ustekinumab-kfce as Sixth Biosimilar to Stelara